The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study by Tang, Tjun Y., MB, BChir, Howarth, Simon P.S., BMBCh (Oxon), Miller, Sam R., MSc, Graves, Martin J., MSc, Patterson, Andrew J., PhD, U-King-Im, Jean-Marie, PhD, Li, Zhi Y., PhD, Walsh, Stewart R., MSc, Brown, Andrew P., BSc, Kirkpatrick, Peter J., FmedSci, Warburton, Elizabeth A., DM, Hayes, Paul D., MD, Varty, Kevin, MD, Boyle, Jonathan R., MD, Gaunt, Michael E., MD, Zalewski, Andrew, PhD, Gillard, Jonathan H., MD

Get full text

Peripheral artery disease, biomarkers, and darapladib by Berger, Jeffrey S., MD, MS, Ballantyne, Christie M., MD, Davidson, Michael H., MD, Johnson, Joel L., PharmD, Tarka, Elizabeth A., MD, Lawrence, Denise, MSc, Trivedi, Trupti, PhD, Zalewski, Andrew, MD, PhD, Mohler, Emile R., MD

Get full text

Assessment on the Prevention of Progression by Rosiglitazone on Atherosclerosis in diabetes patients with Cardiovascular History (APPROACH): Study design and baseline characteristi... by Ratner, Robert E., MD, Cannon, Christopher P., MD, Gerstein, Hertzel C., MD, MSc, Nesto, Richard W., MD, Serruys, Patrick W., MD, PhD, van Es, Gerrit-Anne, PhD, Kolatkar, Nikheel S., MD, MPH, Kravitz, Barbara G., MS, Zalewski, Andrew, MD, PhD, Fitzgerald, Peter J., MD, PhD

Get full text

The Effect of Darapladib on Plasma Lipoprotein-Associated Phospholipase A2 Activity and Cardiovascular Biomarkers in Patients With Stable Coronary Heart Disease or Coronary Heart D... by Mohler, Emile R., MD, FACC, Ballantyne, Christie M., MD, FACC, Davidson, Michael H., MD, FACC, Hanefeld, Markolf, MD, PhD, Ruilope, Luis M., MD, PhD, Johnson, Joel L., PharmD, Zalewski, Andrew, MD

Get full text